Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment. Castellazzi M, Delbue S, Elia F, Gastaldi M, Franciotta D, Rizzo R, Bellini T, Bergamaschi R, Granieri E, Fainardi E Dis Markers. 2015; 2015:901312. Epub 2015 May 26. PMID: 26101453. Abstract CommentRecommendBookmarkWatch